期刊文献+

3D打印在心血管疾病手术中的应用进展 被引量:5

Application Progress of 3D Printing in cardiovascular surgery
下载PDF
导出
摘要 近年来,3D打印在临床上已经广泛应用。本综述阐述心血管疾病中3D打印模型的来源,重点介绍3D打印在先天性心脏病、心脏瓣膜病和肥厚型心肌病等诸多方面手术治疗中的应用,指出3D打印未来的发展方向,并对3D打印的应用进行讨论。 Recent years,3D printing has been widely used in the clinic.This review describes the sources of 3D printing models in cardiovascular diseases,and focuses on the application of 3D printing in surgical treatment of congenital heart disease,valvular heart disease and hypertrophic cardiomyopathy.The future development direction of 3D printing is pointed out and the application of 3D printing is discussed.
作者 卢涛 王水云 LU Tao;WANG Shui-yun(Department of Cardiovascular Surgery,State Key Laboratory of Cardiovascular Disease,Fuwai Hospital,National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037,China)
出处 《中国心血管病研究》 CAS 2021年第5期469-475,共7页 Chinese Journal of Cardiovascular Research
基金 首都卫生发展科研专项基金(首发2020-2-4036) 中国医学科学院中央级公益性科研院所基本科研业务费临床与转换医学研究基金(2019XK320054)。
关键词 3D打印 先天性心脏病 心脏瓣膜病 梗阻性肥厚型心肌病 3D printing Congenital heart disease Valvular heart disease Obstructive hypertrophic cardiomyopathy
  • 相关文献

参考文献2

二级参考文献28

  • 1Maron MS,Olivotto I,Zenovich AG,et al.Hypertrophic cardiomyo-pathy is predominantly a disease of left ventricular outflow tract obstruction.Circulation,2006,114(21):2232-2239.
  • 2Case RB,Morrow AG,Stainsby W,et al.Anomalous origin of the left coronary artery;the physiologic defect and suggested surgical treatment.Circulation,1958,17(6):1062-1068.
  • 3Marian AJ.Contemporary treatment of hypertrophic cardiomyopa-thy.Tex Heart Inst J,2009,36(3):194-204.
  • 4Ommen SR,Maron BJ,Olivotto I,et al.Long-term effects of surg-ical septal myectomy on survival in patients with obstructive hyper-trophic cardiomyopathy.J Am Coll Cardiol,2005,46(3):470-476.
  • 5Morrow AG,Reitz BA,Epstein SE,et al.Operative treatment in hypertrophic subaortic stenosis.Techniques,and the results of pre and postoperative assessments in 83 patients.Circulation,1975,52(1):88-102.
  • 6Minakata K,Dearani JA,Nishimura RA,et al.Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anoma-lous mitral papillary muscles or chordae.J Thorac Cardiovasc Surg,2004,127(2):481-489.
  • 7Maron BJ,Dearani JA,Ommen SR,et al.The case for surgery in obstructive hypertrophic cardiomyopathy.J Am Coll Cardiol,2004,44(10):2044-2053.
  • 8Ryan LP,Jackson BM,Parish LM,et al.Mitral valve tenting index for assessment of subvalvular remodeling.Ann Thorac Surg,2007,84(4):1243-1249.
  • 9Maron BJ.Controversies in cardiovascular medicine.Surgical myec-tomy remains the primary treatment option for severely symptomatic patients with obstructive hypertrophic cardiomyopathy,Circulation,2007,116(2):196-206.
  • 10Maron B J,Estes NR,Maron MS,et al.Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.Circulation,2003,107(23):2872-2875.

共引文献195

同被引文献64

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部